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Background and methods: Stem or progenitor cells from healthy tissues have the capacity to co-segregate their
template DNA strands during mitosis. Here, we set out to test whether breast cancer cell lines also possess the
ability to asymmetrically segregate their template DNA strands via non-random chromosome co-segregation, and
whether this ability correlates with certain properties attributed to breast cancer stem cells (CSCs). We quantified
the frequency of asymmetric segregation of template DNA strands in 12 human breast cancer cell lines, and
correlated the frequency to molecular subtype, CD44+/CD24-/lo phenotype, and invasion/migration ability. We
tested if co-culture with human mesenchymal stem cells, which are known to increase self-renewal, can alter the
frequency of asymmetric segregation of template DNA in breast cancer.
Results: We found a positive correlation between asymmetric segregation of template DNA and the breast cancer
basal-like and claudin-low subtypes. There was an inverse correlation between asymmetric segregation of template
DNA and Her2 expression. Breast cancer samples with evidence of asymmetric segregation of template DNA had
significantly increased invasion and borderline significantly increased migration abilities. Samples with high CD44
+/CD24-/lo surface expression were more likely to harbor a consistent population of cells that asymmetrically
segregated its template DNA; however, symmetric self-renewal was enriched in the CD44+/CD24-/lo population.
Co-culturing breast cancer cells with human mesenchymal stem cells expanded the breast CSC pool and decreased
the frequency of asymmetric segregation of template DNA.
Conclusions: Breast cancer cells within the basal-like subtype can asymmetrically segregate their template DNA
strands through non-random chromosome segregation. The frequency of asymmetric segregation of template DNA
can be modulated by external factors that influence expansion or self-renewal of CSC populations. Future studies to
uncover the underlying mechanisms driving asymmetric segregation of template DNA and dictating cell fate at the
time of cell division may explain how CSCs are maintained in tumors.
Keywords: Non-random chromosome segregation, Asymmetric cell division, Immortal DNA strand hypothesis,
Breast cancer, Cancer stem cellsBackground
In mature organisms, tissue homeostasis is maintained
through a dynamic balance between symmetric and
asymmetric cell divisions of its stem or progenitor cells.
Asymmetric cell division produces unequal daughter
cells; one retains its stem cell properties and the other
acquires a more differentiated phenotype. Similar to
normal stem cells, cancer stem cells (CSCs) are also able
to asymmetrically self-renew. However, CSC divisions* Correspondence: pinesr@cinj.rutgers.edu
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reproduction in any medium, provided the orfavor excessive symmetric self-renewal that drives ex-
pansion of the CSC pool [1-4]. Understanding the
mechanisms driving cell fate decisions during cell
division of CSCs could lead to therapies designed to
deplete the CSC pool.
Non-random co-segregation of sister chromatids dur-
ing mitosis, also known as asymmetric segregation of
template DNA strands, has been reported in various tis-
sues, including mouse embryonic fibroblasts [5], hair
follicles [6], nasopharyngeal epithelium [7], intestinal
epithelium [8], mammary gland epithelium [9,10], and
skeletal muscle [11,12]. Several hypotheses have arisen
to explain these observations including reduction ofThis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and






















Figure 1 Human breast cancer cell lines asymmetrically
segregate their template DNA strands. (A) Schematic
representation of the BrdU labeling assay. Chromosomes
were labeled with BrdU (shown as green lines). BrdU was then
removed from the media and cells were cultured for two cell
divisions. Newly synthesized DNA is shown as blue lines. Due to
semi-conservative DNA replication, asymmetric segregation of
template DNA is apparent at the 2nd anaphase. (B) Representative
images of a HCC1143 cell in anaphase with random segregation of
its template DNA to both sets of chromosomes. (C) Representative
images of an anaphase HCC1143 cell with template DNA segregated
exclusively to one set of chromosomes, on the right bottom. Blue:
DAPI-labeled DNA. Green: BrdU-labeled DNA.
Liu et al. Molecular Cancer 2013, 12:139 Page 2 of 10
http://www.molecular-cancer.com/content/12/1/139cancer-promoting DNA replication errors, and epigen-
etic modification of daughter cells [13], although the
functional relevance has not yet been determined experi-
mentally. Not all tissues harbor cells that asymmetrically
segregate their template DNA [14,15], suggesting that
asymmetric DNA segregation may be restricted to
certain cell lineages. We previously reported that asym-
metric segregation of template DNA is retained in hu-
man non-small cell lung cancer (NSCLC) cell lines and
short-term cultures of primary lung tumors. We showed
that asymmetric segregation of template DNA in
NSCLC results in divergent fates of the daughter cells,
are enriched within the CD133+ CSC fraction, and can
be modulated by changes in the micro-environment
[16]. Subsequently, asymmetric segregation of template
DNA was reported in liver, gastric and colon cancer cell
lines [4,17-19], as well as cultures of malignant pe-
ritoneal mesothelioma stem cells [20]. Furthermore,
label-retaining cells were detected in nasopharyngeal
carcinoma tissues [7]. Here, we set out to determine if
asymmetric segregation of template DNA occurs in hu-
man breast cancer cell lines, if the frequency of asym-
metric segregation of template DNA correlates with
certain CSC-like features, and if it can be modulated by
external factors that influence expansion or self-renewal
of CSC populations.
Results
Breast cancer cells asymmetrically segregate their
template DNA strands during cell division
To verify whether human breast cancer cells asym-
metrically segregate their template DNA strands, clas-
sical Bromodeoxyuridine (BrdU) pulse-labeling strategies
were performed as described [16] (Figure 1A). Twelve
human breast cancer cell lines were cultured in the pres-
ence of BrdU for at least 2 weeks to ensure that all the
cells and DNA strands were labeled. Staining cells with
anti-BrdU antibody at the second anaphase following
BrdU removal revealed that the majority of cells segre-
gated their DNA templates randomly (Figure 1B). As
was previously observed in NSCLC [16], a low percent-
age of anaphase cells in several cell lines showed evi-
dence of BrdU-labeled template chromosomes that were
segregated exclusively to one side of the metaphase
plate, whereas the other set of chromosomes was com-
pletely devoid of BrdU label (Figure 1C). However, in
contrast to NSCLC in which the vast majority of sam-
ples showed evidence for asymmetric segregation of
template DNA [16], we observed quantifiable asym-
metric segregation of template DNA in only 5 of the
12 breast cancer cell lines (Figure 1A). The frequency of
non-random chromosome segregation ranged from
6.47 ± 0.62% to 0.50 ± 0.32% (Figure 2A, Table 1). We
did not observe any cells with asymmetric segregation oftemplate DNA among 1,200 anaphases each in MDA-
MB-468, HCC1954, MCF7, T47D, or MDA-MB-361
cells. Two additional cell lines, MDA-MB-453 and
SKBR3, had sporadic low-level asymmetric segregation






Figure 2 Frequency of asymmetric segregation of template
DNA and correlation with Her2 expression. (A) Percentages of
cells with asymmetric division of BrdU-labeled DNA templates are
shown for 12 breast cancer cell lines. Analyses were performed in
triplicates in triplicates and at least two independent experiments
were performed. Basal cell lines had a higher frequency of ACD as
compared to luminal cell lines (P = 0.03, Fisher’s exact test) (B) The
breast cancer cell lines were divided into two groups according
to the percentage of BrdU asymmetric division observed, high
asymmetry (mean, ≥ 0.5%, which was the limit of quantifiable
detection) and low asymmetry (mean, <0.5%). Relative Her2
expression, as assessed by flow cytometry in at least two independent
experiments, is shown as mean fluorescence intensity. Cell lines with
high asymmetry had lower Her2 expression as compared to cell lines
with low asymmetry (P = 0.02, Mann–Whitney test). Error bars are
standard error of the mean.
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the actual frequency was just at or below the detection
threshold and could not be accurately quantified. In all
subsequent analyses, cell lines were grouped into those
with quantifiable levels of asymmetric segregation of
template DNA versus those with very low or no detec-
table levels.
Asymmetric segregation of template DNA varies by
molecular breast cancer subtype
Breast cancer is a molecularly and phenotypically diverse
disease composed of distinct biological subtypes with
differing responses to therapy. To assess if the wide vari-
ations in frequency of asymmetric segregation of tem-
plate DNA could be due to differences in breast cancer
subtypes, we grouped the 12 cell lines into basal-like and
luminal [21]. The cell lines with consistently observed
asymmetric segregation of template DNA were basal-
like, whereas none of the luminal breast cancer cell lines
had consistent asymmetric segregation of template DNA
(P = 0.03) (Figure 2A). The basal-like phenotype can be
further classified into a claudin-low molecular subtype
[22] that is enriched for markers associated with breast
CSCs [23]. Four of the cell lines in our panel, MDA-
MB-231, MDA-MB-157, HBL100, and BT549 were
previously classified as claudin-low [23]. The claudin-
low cell lines in our panel were significantly more likely
to harbor a consistent population of cells with asym-
metric segregation of template DNA as compared to
the remainder of the basal-like and luminal cell lines
(P = 0.01). This suggests that asymmetric chromosome seg-
regation in breast cancer is molecular subtype-dependent
and may be enriched in claudin-low breast tumors.
We next considered specific features that correspond
with breast cancer subtypes that may participate in regu-
lating self-renewal. Her2 is overexpressed more fre-
quently in the luminal subtype, and is associated with
poor prognosis and increased breast cancer recurrence
[24]. Furthermore, in the ErbB2 transgenic mouse model
of breast cancer, Her2 is constitutively activated in the
mammary epithelium, resulting in expansion of mam-
mary CSCs through decreased asymmetric and increased
symmetric self-renewing divisions [1]. Consistent with
the ErbB2 mouse model of breast cancer, we observed a
positive correlation between low Her2 mean fluores-
cence intensity (MFI) levels and breast cancer cell lines
with quantifiable asymmetric segregation of template
DNA (P = 0.02) (Figure 2B and Table 1).
The p53 pathway is known to participate in increased
asymmetric self-renewal. Wild-type p53 expression was
reported to increase non-random chromosome segrega-
tion in fibroblasts and epithelial cells [25], and there was
an expansion of primary premalignant mouse mammary
stem cells when TP53 was deleted [1]. Only two of the
Table 1 Frequencies of BrdU asymmetric division, surface marker expression and functional assays in breast cancer
cell lines
Cell line % Asymmetric % CD44+/ HER2 No. invaded No. migrated Soft agar
cell division* CD24-/lo (MFI) cells* cells* colony no.*
Basal
MDAMB231 6.5 ± 0.6 99.9 9.4 83.5 ± 0.0 75.0 ± 5.9 45 ± 7
HCC1143 6.3 ± 0.6 16.4 0 0.9 ± 0.3 4.9 ± 0.5 0
MDAMB157 1.0 ± 0.3 97.4 73.5 32.0 ± 1.7 50.4 ± 2.6 0
HBL100 0.6 ± 0.4 81.3 16.4 14.7 ± 1.5 9.3 ± 1.1 99 ± 16
BT549 0.5 ± 0.3 90.3 0.4 14.1 ± 3.7 171.0 ± 8.2 0
MDAMB468 0 1.6 2.9 3.2 ± 0.3 42.6 ± 1.4 390 ± 35
HCC1954 0 2.5 851.9 20.4 ± 2.9 46.8 ± 2.5 1 ± 1
Luminal
MDAMB453 ≤ 0.25 0 648.9 1.9 ± 0.2 5.9 ± 0.7 0
SKBR3 ≤ 0.25 0 1478.8 0.4 ± 0.1 3.7 ± 0.4 0
MCF7 0 3.8 279.7 0.2 ± 0.1 2.8 ± 0.6 1 ± 0
T47D 0 0 89.7 0.6 ± 0.2 6.4 ± 0.3 13 ± 4
MDAMB361 0 0.8 586.2 0.3 ± 0.1 3.3 ± 0.4 0
*Values were expressed as mean ± standard error of the mean.
MFI Mean fluorescence intensity.
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MCF7) were wild-type for TP53 [26] (http://p53.free.fr/),
and therefore we did not assess the correlation between
p53 status and asymmetric segregation of template DNA
in this study.
Correlation of asymmetric segregation of template DNA
frequency with CSC phenotype and function
It was previously hypothesized that when normal stem
cells or CSCs asymmetrically segregate their temple
DNA, they retain their original chromosomes and pass
their newly synthesized DNA to differentiating daughter
cells [13,16,17]. We therefore posited that breast cancer
samples with a high percentage of CSCs would be more
likely to harbor asymmetrically dividing cells. To test
this, we examined breast CSC-associated surface
markers by flow cytometry and performed functional
CSC assays on all twelve breast cancer cell lines in our
panel. We first evaluated expression of CD44 and CD24,
since CD44+/CD24-/lo is a well-established surface CSC
phenotype for breast cancer as well as stem cells in nor-
mal breast tissues [27-29]. The percentage of cells within
the CD44+/CD24-/lo fraction varied substantially among
different cell lines, consistent with previous reports
(Table 1) [30]. Cell lines that had a consistent population
of cells harboring asymmetric segregation of template
DNA also had a higher percentage of CD44+/CD24-/lo
cells (P = 0.004) (Figure 3A), suggesting that cell lines
with a high CD44+/CD24-/lo fraction are enriched in
cells undergoing asymmetric segregation of template
DNA.To test whether asymmetric segregation of template DNA
may be enriched within the putative CSC CD44+/CD24-/lo
fraction, we examined this fraction after it was isolated
by cell sorting. The sorted MCF7 CD44+/CD24-/lo CSC
fraction did not harbor any cells with detectable asym-
metric segregation of template DNA (Figure 3B). To
verify these findings, we sorted HCC1143 cells, whose
bulk population had a larger 16.4% CD44+/CD24-/lo
population and a substantial 6.3% of cells that had
asymmetric segregation of template DNA. We observed
no enrichment for cells that asymmetrically segregated
its template DNA within the CSC-sorted population.
The CD44+/CD24-/lo fraction had a nearly two-fold de-
creased frequency of asymmetric segregation of tem-
plate DNA as compared to the non-CSC fraction
(Figure 3B). These data suggest that the CD44+/CD24-/lo
CSC population might undergo more symmetric
self-renewing divisions as compared to the bulk
population within basal-like subtypes, and that asym-
metric segregation of template DNA is breast cancer
subtype-dependent.
High aldehyde dehydrogenase (ALDH) activity is an-
other marker for breast CSCs and predictor of poor out-
come [31]. Two isoforms, ALDH1A1 and ALDH1A3
have been implicated in driving ALDH1 activity [32,33].
We examined expression of ALDH1A1 and ALDH1A3
in our panel of 12 cell lines by flow cytometry and com-
pared them to the frequency of asymmetric segregation
of template DNA. No significant correlation was ob-
served (ALDH1A1, P = 0.68; ALDH1A3, P = 0.12, Data















Figure 3 Asymmetric segregation of template DNA is
correlated with CD44+/CD24-/lo expression. (A) Breast cancer cell
lines were divided into two groups according to the percentage of
BrdU asymmetric division observed, high asymmetry (mean, ≥ 0.5%)
and low asymmetry (mean, < 0.5%), then plotted against the
percentage of cells that were CD44+/CD24-/lo. Cell lines with high
asymmetry had a higher percentage of cells that were CD44+/CD24-/lo
as compared to cell lines with low asymmetry (P = 0.004, Mann–Whitney
test). Samples were analyzed in triplicates and in at least two
independent experiments. (B) Fold-change in frequency of
asymmetric segregation of template DNA in HCC1143 cells, normalized
to parental-unsorted population (unsorted), are shown for cells
that were sorted without gating (sham sorted), sorted stem cells
(CD44+/CD24-/lo), and sorted cells negative for the CD44+/CD24-/lo
immunophenotype (not CD44+/CD24-/lo). Error bars are standard
error of the mean.
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of the two main enzymes responsible for ALDH activity,
we did not perform an ALDH activity assay on the
breast cancer cell lines.
We next evaluated invasion and migration abilities
within our breast cancer panel (Figure 4A and B,
Table 1). We observed a statistically significant positive
correlation between the frequency of asymmetric segre-
gation of template DNA and invasion ability (P = 0.04),
and a non-significant trend with cell migration (P =
0.06), suggesting that breast cancers with the capacity
for asymmetric segregation of template DNA may have
an increased ability to metastasize. Soft agar colony as-
says were also performed to assess the clonogenic cap-
acity of the breast cancer cell line panel. However, no
correlation was observed between clonogenic capacity
and asymmetric segregation of template DNA (Table 1).
Mesenchymal stem cells promote symmetric self-renewal
in breast cancer
Mesenchymal stem cells (MSCs) are progenitors within
the bone marrow stroma that have been shown to not
only support breast cancer growth in vitro and in vivo
[34,35], but also to expand the breast CSC population
[36]. To further investigate the functional relevance of
asymmetric segregation of template DNA, we quantified
its frequency in breast cancer cells when co-cultured
with human bone marrow-derived MSCs. For two of the
cell lines that had the highest population of cells that
asymmetrically segregate their template DNA, MDA-
MB-231 and HCC1143, co-culture with human MSCs
significantly decreased the percentage of cells that had
asymmetric segregation of template DNA, from 6.47 ±
0.63% to 0.99 ± 0.28%, and from 6.25 ± 0.62% to 1.5 ±
0.35%, respectively (Figure 5A). Because co-culturing
with human MSCs decreased the frequency of asymmet-
ric segregation of template DNA, cell lines that lacked
evidence for asymmetric segregation of template DNA
were excluded from analysis. The decrease in frequency
of asymmetric segregation of template DNA could have
arisen from two scenarios: either the mother cell under-
went symmetric self-renewal to give rise to two daughter
cells with similar stem-like characteristics, or it under-
went symmetric differentiation, to give rise to two
daughter cells that are both differentiating. To test these
scenarios, we co-cultured 3 breast cancer cell lines with
human MSCs and analyzed expression of CD44 and
CD24 (Figure 5B). We observed a substantial increase in
the CD44+/CD24-/lo cell fraction in HCC1143 and T47D
cells when co-cultured with MSCs (P < 0.05). As ex-
pected, there was no increase in percentage of cells ex-
pressing CD44+/CD24-/lo in MDA-MB-231 cells because
nearly 100% of the untreated cells were CD44+/CD24-/lo.




































Figure 4 Asymmetric segregation of template DNA is
correlated with invasion and migration abilities. (A-C) The breast
cancer cell lines were subjected to invasion and migration assays, and
the number of cells that invaded (A) and migrated (B) are shown.
Experiments were performed in triplicates and in at least two
independent assays. The breast cancer cell lines were divided into
two groups according to the percentage of BrdU asymmetric division
observed, high asymmetry (mean, ≥0.5%) and low asymmetry
(mean, <0.5%). (C) Representative images of invaded MDA-MB-231 and





















Figure 5 Mesenchymal stem cells increase breast cancer cell
symmetric self-renewing divisions and decreases frequency of
asymmetric segregation of template DNA. (A) Cells were grown
with MSCs after BrdU was removed, and examined for changes in
asymmetric segregation of template DNA. Percentages of
asymmetric segregation of template DNA are shown with standard
error of the mean of triplicate co-culture experiments. (B) The
percentage of breast cancer cells expressing the CD44+/CD4-/lo
immunophenotype was quantified by flow cytometry before and
after they were co-cultured with MSCs.
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lates with decreased frequency of asymmetric segrega-
tion of template DNA.
Discussion
During embryonic development and tissue homeostasis,
asymmetric cell division allows stem cells to give rise to
one daughter stem cell (self-renewal) and another that is
destined to differentiate. It is generally believed that, in
normal tissues, asymmetric self-renewal is restricted to
stem or progenitor cells. We previously extended this
knowledge to lung cancer [16]. Others recently observed
similar findings in hepatocellular carcinoma, gastric
cancer, colon cancer, and peritoneal mesothelioma
[4,17,18,20]. In this study, we show evidence of asym-
metric segregation of template DNA in breast cancer.
This is the first report to show a marked heterogeneity
in frequency of asymmetric segregation of template
DNA across cell lines that correlates with molecular
subtype. Consistent evidence for asymmetric segregation
of template DNA was found exclusively among cell lines
within the basal-like breast cancer subtype, whereas the
remainder of cell lines, which were mainly luminal,
showed no evidence of consistent asymmetric segrega-
tion of template DNA. More studies are needed to con-
firm these observations, particularly in primary breast
cancer. Furthermore, studies on asymmetric cell division
within different cell lineages in the mammary gland
might shed light on whether the association between
asymmetric segregation of template DNA and the basal-
like phenotype is cell-lineage dependent or a feature
arising during neoplastic development.
We observed an inverse correlation between asymmet-
ric segregation of template DNA and cell surface Her2
expression. Since Her2 expression in breast tumors is as-
sociated with unfavorable prognosis [24], this may indi-
cate that symmetrically dividing, self-renewing stem cells
tend to be more aggressive. Furthermore, our observa-
tion is consistent with the findings by Cicalese et al., in
which constitutive activation of Her2 in the ErbB2 mur-
ine breast cancer model results in excessive self-renewal
and decreased asymmetric cell divisions [1]. The inverse
correlation between Her2 expression and asymmetric
segregation of template DNA could also be due to the
fact that most Her2+ breast cancer cell lines fall into the
luminal subtype [37], or that the frequency of asymmet-
ric segregation of template DNA in Her2+ breast can-
cers is below our sensitivity limit of detection. In
addition, breast cancer patients with an inherited TP53
mutation are more likely to present with amplification of
HER2 [38], and TP53 mutations result in expansion of
primary premalignant mouse mammary stem cells [1].
Since wild-type p53 increases the kinetics of immortal
DNA strand co-segregation [25], the potential linkbetween Her2 and asymmetric segregation of template
DNA may be partly due to TP53 status. Additional
breast cancer samples should be tested and further stud-
ies are needed to determine if Her2 expression and/or
p53 actively participate in asymmetric segregation of
template DNA in human breast cancer.
Cell lines with high percentages of asymmetric segre-
gation of template DNA were enriched for cells that
expressed the breast CSC-associated CD44+/CD24-/lo
markers on their cell surface, and had significantly
higher invasive capability, as compared to cell lines with
no or barely detectable asymmetric segregation of
template DNA. These data suggest that cell lines with
more CSC-like properties have higher percentages of
asymmetric segregation of template DNA. This trend
could also be due to the fact that basal-like cell lines
harbor a higher fraction of CD44+/CD24-/lo cells [37]
and have much higher invasive ability [21]. Enriched
CD44+/CD24-/lo luminal MCF7 cells did not harbor de-
tectable asymmetric segregation of template DNA
among sorted CD44+/CD24-/lo cells, suggesting that the
differences in frequency of non-random chromosome
segregation among cell lines were not due to differences
in the CD44+/CD24-/lo populations. This was supported
by the fact that CD44+/CD24-/lo cells isolated from
HCC1143 cells also did not show enrichment in fre-
quency of asymmetric segregation of template DNA.
However, because the sample size was small, a larger
study is warranted.
When basal-like breast cancer cells were co-cultured
with bone marrow-derived MSCs, there was a marked
increase in the breast CSC population [36]. When we
co-cultured breast cancer cells with MSCs, we observed
a marked expansion of the CD44+/CD24-/lo CSC popula-
tion, and a switch from asymmetric to symmetric segre-
gation of template DNA. Future studies are needed to
determine if MSCs increase the breast CSC pool directly
by shifting the balance from asymmetric cell division to
symmetric self-renewal. Furthermore, studies are needed
to determine if the positive feedback cytokine loop in-
volving IL6 and CXCL7, that has been shown to increase
the breast CSC fraction within breast cancer cell lines
and mouse xenografts [36], participates in the decrease
in frequency of asymmetric segregation of template
DNA when breast cancer cells are exposed to MSCs.
According to classical DNA analog pulse-labeling or
pulse-chase assays, the DNA analog, e.g., BrdU, cannot
be incorporated into the template DNA strands if
the stem cell undergoes repeated non-random chromo-
some segregation [5,11,12,39]. However, template DNA
strands are “born” in certain cases when the stem cell
expands via symmetric division during normal develop-
ment, injury repair, or exponential growth of cancer. We
previously showed that during in vitro expansion of lung
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often interrupted by intervening symmetric divisions,
and we surmised that a propensity towards excessive
self-renewal via symmetric divisions among CSCs con-
tributes to the exponential expansion of tumors [16].
Conversely, if the template DNA is not labeled during
the two-week pulse period, then asymmetric segregation
of the BrdU-labeled newly synthesized DNA would be
observed during the first anaphase following BrdU re-
moval. We did not observe any asymmetric BrdU segre-
gation during the first cell division after BrdU removal
in any of the cell lines (Data not shown), suggesting that
both template and newly synthesized DNA were labeled
during the long pulse period. Further studies would be
needed to determine if the daughter cells retaining the
BrdU-labeled template chromosomes are breast CSCs or
differentiating daughter cells. In addition, studies involv-
ing a classical “chase” period following the BrdU pulse,
in which an excess of thymidine is used to more rapidly
eliminate the BrdU, may improve sensitivity.
Several hypotheses have been proposed to explain
asymmetric segregation of template DNA strands. The
immortal strand hypothesis was proposed decades ago
by John Cairns [39] and states that normal stem cells
protect the integrity of the genome by retaining the ori-
ginal copy of their DNA template, thus preventing the
accumulation of mutations during replication. However,
the proposal has been challenged by the fact that repli-
cation errors are not the only cause of DNA mutations
during stem cell divisions. An alternative, though not
mutually exclusive, explanation is that differences in epi-
genetic markers between the two copies of chromo-
somes direct divergent cell fates [40]. Both hypotheses
support the evidence that asymmetric segregation of
template DNA in stem cells is correlated with cell fate
determination in daughter cells, although it is unclear if
asymmetric segregation of template DNA in non-stem
cells results in differing cell fates. Notwithstanding,
exposure of cancer cells with an agent that increases
self-renewal, i.e., MSCs, will increase the CSC pool by al-
tering the balance between asymmetric and symmetric
cell divisions. This implies that shifting the balance to
symmetric differentiated divisions could deplete the CSC
pool.
Although asymmetric segregation of template DNA and
label-retaining cells from various organisms and tissues
have been studied [5-12,41-43], there have also been re-
ports on failure to find this phenotype [14,15,44-52]. We
now show that asymmetric segregation of template DNA
occurs in breast cancer cell lines, in accordance with previ-
ous lung cancer cell lines and primary lung tumors [16], as
well as other cancer types [4,17,18,20]. The controversy in
the literature could be partly due to differences in organ-
isms, tissues, environment, timing as well as experimentalapproaches. Understanding the mechanisms driving asym-
metric segregation of template DNA could clarify stem cell
determination in normal tissues, and provide insights into
the mechanisms of cancer cell hierarchy. Specific treatment
targeting self-renewing symmetric divisions could then be a
potentially effective cancer therapy.
Materials and methods
Cell culture
Human breast cancer cell lines MDA-MB-231, MCF7,
MDA-MB-157, SKBR3 and MDA-MB-361 cells were
grown in DMEM medium (Invitrogen), MDA-MB-468,
T47D and MDA-MB-453 were grown in DMEM/F12
medium (Invitrogen) and BT549, HBL100, HCC1954
and HCC1143 were grown in RPMI medium (Invitro-
gen). All growth media were supplemented with 100U/
ml penicillin, 0.1 mg/ml streptomycin (Invitrogen), 2
mM glutamine (Invitrogen), and 10% FBS (Sigma). Cells
were cultured in a standard incubator under ambient O2
concentrations with 5% CO2 at 37°C. All cell lines tested
were authenticated by Genetica DNA Laboratories.
Asymmetric segregation of template DNA assay
Asymmetric segregation of template DNA was quanti-
fied exactly as described [16]. Briefly, cells were cultured
in the presence of 1 μM BrdU for at least 2 weeks to en-
sure all the cells were labeled. Cells were then cultured
for two population doublings in the absence of BrdU,
and then were either collected by mitotic shake-off, or
stained directly on glass slides. Population doubling
times were determined beforehand in at least two inde-
pendent experiments, under the same conditions as used
for detecting asymmetric segregation of template DNA.
Mitotic cells were fixed in cold 70% ethanol for at least
30 min., then exposed to 2 N HCl with 0.5% Triton-X-
100 for 1 hr. After washing, cells were incubated with a
1:10 dilution of anti-BrdU-FITC (BD Biosciences). Slides
were washed, dried and mounted using Vectashield con-
taining DAPI (Vector Laboratories) [16].
BrdU asymmetric division was imaged and manually
scored by visualization of anaphase cells using a Nikon
TE200 microscope with DS-Ri1 camera and NIS-
Elements BR software. Cells were scored as described in
detail [16]. Complete BrdU segregation to one set of
chromosomes and absence of any BrdU in the other was
considered as asymmetric segregation of template DNA.
For every cell line, scoring was performed on three repli-
cates, each with ≥200 anaphase cells, and repeated at
least once.
Flow cytometry and cell sorting
Cells were trypsinized, washed with PBS/0.5% BSA, then
primary antibody was added and incubated for 30 min
on ice. After washing, 7-AAD (BD Biosciences) was
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used for setting gates. For detection of ALDH1A1 and
ALDH1A3, cells were fixed then permeabilized in 4%
paraformaldehyde followed by 0.5% Triton-X-100 before
incubation with the primary antibody. Secondary anti-
body was Alexafluor 488 anti-Rb (Invitrogen). Analysis
was performed on a FACscalibur flow cytometry ma-
chine using CellQuest Pro software. Antibodies used
were: APC-conjugated anti-CD44 (BD Pharmigen);
FITC-conjugated anti-CD24 (BD Pharmingen); APC-
conjugated anti-ErbB2 (R&D Systems); rabbit anti-
ALDHA1 (ABGENT); rabbit anti-ALDHA3 (ABGENT).
For cell sorting experiments, cells were cultured in the
presence of 1 μM BrdU for at least 2 weeks and then
stained as above for flow cytometry, then sorted using a
BD Biosciences Influx High Speed Cell Sorter. Post-sort
purity checks confirmed the purity of the sorted popula-
tions. Sorted cells were cultured in the absence of BrdU
for 2 population doublings, and then examined for
asymmetric segregation of template DNA, as explained
above.
Invasion and migration assay
Eight micron cell culture inserts were placed in compan-
ion plates (BD Biosciences). For invasion assays, cell cul-
ture inserts were coated with Matrigel (BD Biosciences)
diluted to 1g/L in serum-free cell culture media for the
specific cell line. For both invasion and migration assays,
cells were harvested using trypsin and washed twice in
cell culture media without serum. Cells, 1 × 105 or
1.25 × 104, were added to the invasion or migration
chambers, respectively. The lower chambers were filled
with 0.6 ml of cell culture media with 10% FBS as a
chemo-attractant. Chambers were then incubated at
37°C for 24 hrs. Cells on the upper surface of the inserts
were removed gently using cotton swabs. Cells on the
lower surface were fixed and stained in 0.05% crystal
violet for 10 min. Counting of the invaded or migrated
cells was performed using a 10X objective on a Nikon
TMS microscope on five independent fields. All experi-
ments were done in triplicate and repeated at least once.
If there were too few cells in each field of view during
counting, the starting number of plated cells were then
doubled or quadrupled.
Soft agar colony assay
Cells (1 × 104) were suspended in 0.425% Noble agar
(BD Biosciences) in culture medium above a 0.625%
agar-medium base layer in 6 cm dishes. An additional
0.625% agar-medium layer was applied above the cell
layer. Agar plates were incubated in a standard cell cul-
ture incubator, were topped with 1 ml complete cell cul-
ture media that was replaced once a week for 3 weeks,
and then stained in 0.005% crystal violet for 1 hr. Plateswere scanned using MP Navigator EX1.0 software using
a Canon 8800F scanner. Colonies with 10 or more cells
in diameter were counted using ImageJ software (http://
rsbweb.nih.gov/ij). Every cell line was assayed in two in-
dependent experiments, each with three replicates.
Co-culture of breast cancer cells with MSCs
Human bone marrow-derived MSCs harvested from
pooled normal human donors were purchased from
Lonza, and expanded for 3 passages in Mesenchymal
Stem Cell Growth Medium (Lonza). For co-culture flow-
cytometry experiments, MSCs were labeled with Cell
Tracker Red (CTR) (Invitrogen) and grown with breast
cancer cells for 3 days in the cell culture media used for
the cell line, such that the final confluence of the flask
was ≤ 90%. Flow cytometry on co-cultured breast cancer
cells was performed as described above, except the
MSCs were excluded from analyses by gating out CTR
fluorescence. Asymmetric segregation of template DNA
during cell division was quantified by a colony-forming
assay as described. Specifically, 300 breast cancer cells
that were grown in the presence of 1 μM BrdU for at
least two weeks were labeled with CTR and then plated
at clonal density on glass slides with a final 1:1 ratio of
the same cell line (not BrdU-pulsed or CTR-labeled) and
MSCs, such that the confluence at the end of the assay
was ≤ 90%. Slides were fixed and stained once small col-
onies (4–6 cells) were formed. Asymmetric segregation
of template DNA was determined based on inheritance
pattern of BrdU in the progeny, as described [16].
Statistical analysis
Statistics were performed using Stata software, version
12. Comparison between asymmetric segregation of tem-
plate DNA and breast cancer molecular subtype was
done by a Fisher’s exact test. Comparison between asym-
metric cell division and Her2 MFI, and percentage of
cells with CD44+/CD24-/lo expression, invasion and mi-
gration capacity, and colony formation was performed
by a non-parametric Mann–Whitney test. P values 0.05
or below were considered statistically significant.
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